Ronapreve and regdanvimab anti-Covid treatments soon on the European market

Smith Collection/Gado via Getty Images

The coronavirus variants renamed by the WHO with Greek letters (Illustrative photo created by the US CDC of the structure of Sars-Cov-2)

COVID-19 – New weapons to fight Covid-19. The European regulator announced this Thursday, November 11 that it had approved for the first time the marketing in the European Union of two monoclonal antibody treatments against the coronavirus.

The European Medicines Agency (EMA) said in a statement that it had approved the use of a treatment from the Swiss pharmaceutical company Roche, Ronapreve, and a treatment from the South Korean company Celltrion, regdanvimab.

“Ronapreve and Regkirona are the first monoclonal antibody drugs to receive a positive opinion (…) against Covid-19,” said Amsterdam-based EMA.

EU Health Commissioner Stella Kyriakides said approval of the two drugs was an “important step” against the disease, with the EU relying so far on four vaccines.

Target of 5 new treatments by the end of the year

“With increases in Covid-19 contamination in almost all Member States, it is reassuring to see many promising treatments in development as part of our therapeutic strategy against Covid-19”, she added in a communicated.

“Today we are taking an important step towards our goal of authorizing up to five new treatments in the EU by the end of the year,” she added.

In France, the Haute Autorité de Santé (HAS) had already issued in August an “authorization for early access” to Ronapreve treatment for people who are immunocompromised or for whom the vaccination does not work. This procedure allows certain patients to benefit from a medicinal product before it receives a marketing authorization for the indication concerned.

Antibodies are one of the building blocks of our immune system. Faced with the presence of a dangerous element, such as a virus, our body naturally produces it to identify the invader.

The idea of ​​synthetic antibodies is to select natural antibodies and reproduce them artificially to then administer them as a treatment, generally by infusion.

See also on The HuffPost: Why France has ordered 50,000 doses of anti-Covid pills

Source: Le Huffington Post by

*The article has been translated based on the content of Le Huffington Post by If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!